Belpointe Asset Management LLC - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 514 filers reported holding VANECK VECTORS ETF TR in Q1 2020. The put-call ratio across all filers is 0.82 and the average weighting 0.7%.

Quarter-by-quarter ownership
Belpointe Asset Management LLC ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2023$340,610
-29.0%
12,657
-20.6%
0.04%
-31.4%
Q2 2023$479,905
-58.8%
15,938
-55.8%
0.05%
-19.0%
Q1 2023$1,166,179
+3.1%
36,049
-8.7%
0.06%
-7.4%
Q4 2022$1,131,512
+86.7%
39,481
+35.1%
0.07%
+65.9%
Q3 2022$606,000
+59.5%
29,233
+27.5%
0.04%
+64.0%
Q2 2022$380,000
-37.7%
22,935
+44.1%
0.02%
-32.4%
Q1 2022$610,000
+31.2%
15,914
+9.5%
0.04%
+27.6%
Q4 2021$465,000
-64.7%
14,539
-67.5%
0.03%
-67.8%
Q3 2021$1,318,000
-31.4%
44,724
-20.9%
0.09%
-34.8%
Q2 2021$1,922,000
+43.8%
56,558
+37.4%
0.14%
+21.1%
Q1 2021$1,337,000
-24.2%
41,156
-15.9%
0.11%
-27.8%
Q4 2020$1,764,000
+195.0%
48,959
+139.6%
0.16%
+285.4%
Q3 2020$598,000
+57.4%
20,431
+97.4%
0.04%
-16.3%
Q2 2020$380,000
+31.9%
10,352
-17.2%
0.05%
-2.0%
Q1 2020$288,000
-26.5%
12,506
-6.6%
0.05%0.0%
Q4 2019$392,000
+154.5%
13,394
+131.8%
0.05%
+100.0%
Q3 2019$154,000
+52.5%
5,778
+46.9%
0.02%
+25.0%
Q2 2019$101,0003,9320.02%
Other shareholders
VANECK VECTORS ETF TR shareholders Q1 2020
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$20,220,00066.82%
Baymount Management LP 145,000$3,970,00028.08%
New Harbor Financial Group, LLC 1,371,341$37,547,00018.51%
New Harbor Financial Group, LLC 1,291,700$35,366,00017.44%
MKP Capital Management, L.L.C. 1,500,000$41,070,00013.74%
Windmill Hill Asset Management Ltd 844,600$23,125,00011.94%
Hollow Brook Wealth Management LLC 768,567$21,043,00011.57%
Grand Central Investment Group 261,915$7,171,00010.33%
Point72 Europe (London) LLP 1,467,000$40,166,0008.50%
Slate Path Capital LP 4,600,000$125,948,0007.87%
View complete list of VANECK VECTORS ETF TR shareholders